After passing one speed bump, is the market heading towards more bumps in the road? Following the September sell-off, there has been a …

Who’s next? After Gilead snapped up Immunomedics for $21 billion in September, gaining access to Trodelvy, an antibody conjugate that could be used …

Election day is just around the corner, and Wall Street is placing its bet on a Democratic sweep. Following the Presidential debate on …

Lines drawn in the sand in Washington D.C.

Out on Wall Street, one group of stocks divides investors into either fans or critics. Penny stocks, or tickers that trade for less …

It can happen in a New York minute. We are talking about the massive gains certain healthcare stocks are able to notch in …

Since 2019, the healthcare sector has been bracing for the wild ride that would be the election year. However, according to some Street …

A new wave of optimism is splashing onto the Street. Investment firm Goldman Sachs just gave its three-month stock forecast a boost, lifting …

Bull or bear market, no investment is a sure thing. Especially in the current financial environment, which remains riddled with uncertainty, finding compelling …

For those that thought the extreme market volatility was behind us, think again. This month, another burst of volatility was brought on by …